XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Stockholders' Equity
Common Stock
Capital In Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2021     127,311,985          
Beginning balance at Dec. 31, 2021 $ 637,235 $ 637,175 $ 1,273 $ 174,288 $ 1,775,751 $ 12,143 $ (1,326,280) $ 60
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 59,074 59,010     59,010     64
Dividends declared (20,279) (20,279)     (20,279)      
Currency translation adjustments 5,365 5,365       5,365    
Derivative financial instruments 44 44       44    
Defined benefit obligations 651 651       651    
Available-for-sale investments (24) (24)       (24)    
Shares placed in treasury (26,011) (26,011)         (26,011)  
Stock-based compensation charges (in shares)     279,242          
Stock-based compensation charges 3,958 3,958 $ 3 3,955        
Distributions to noncontrolling interests (59)             (59)
Ending balance (in shares) at Mar. 31, 2022     127,591,227          
Ending balance at Mar. 31, 2022 659,954 659,889 $ 1,276 178,243 1,814,482 18,179 (1,352,291) 65
Beginning balance (in shares) at Dec. 31, 2021     127,311,985          
Beginning balance at Dec. 31, 2021 637,235 637,175 $ 1,273 174,288 1,775,751 12,143 (1,326,280) 60
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 133,755              
Currency translation adjustments (9,916)              
Ending balance (in shares) at Jun. 30, 2022     127,604,870          
Ending balance at Jun. 30, 2022 704,350 704,286 $ 1,276 183,251 1,868,822 3,261 (1,352,324) 64
Beginning balance (in shares) at Mar. 31, 2022     127,591,227          
Beginning balance at Mar. 31, 2022 659,954 659,889 $ 1,276 178,243 1,814,482 18,179 (1,352,291) 65
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 74,681 74,613     74,613     68
Dividends declared (20,273) (20,273)     (20,273)      
Currency translation adjustments (15,281) (15,281)       (15,281)    
Derivative financial instruments (240) (240)       (240)    
Defined benefit obligations 651 651       651    
Available-for-sale investments (48) (48)       (48)    
Shares placed in treasury (33) (33)         (33)  
Stock-based compensation charges (in shares)     13,643          
Stock-based compensation charges 5,008 5,008   5,008        
Distributions to noncontrolling interests (69)             (69)
Ending balance (in shares) at Jun. 30, 2022     127,604,870          
Ending balance at Jun. 30, 2022 $ 704,350 704,286 $ 1,276 183,251 1,868,822 3,261 (1,352,324) 64
Beginning balance (in shares) at Dec. 31, 2022 127,671,756   127,671,756          
Beginning balance at Dec. 31, 2022 $ 748,355 748,310 $ 1,277 189,263 1,932,970 (21,930) (1,353,270) 45
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 60,993 61,092     61,092     (99)
Dividends declared (21,231) (21,231)     (21,231)      
Currency translation adjustments 1,694 1,694       1,694    
Derivative financial instruments 554 554       554    
Defined benefit obligations 657 657       657    
Available-for-sale investments (9) (9)       (9)    
Exercises of stock options (in shares)     3,000          
Exercises of stock options 72 72 $ 2 70        
Shares placed in treasury (6,903) (6,903)         (6,903)  
Stock-based compensation charges (in shares)     293,961          
Stock-based compensation charges 3,893 3,893 $ 1 3,892        
Distributions to noncontrolling interests (67)             (67)
Ending balance (in shares) at Mar. 31, 2023     127,968,717          
Ending balance at Mar. 31, 2023 $ 788,008 788,129 $ 1,280 193,225 1,972,831 (19,034) (1,360,173) (121)
Beginning balance (in shares) at Dec. 31, 2022 127,671,756   127,671,756          
Beginning balance at Dec. 31, 2022 $ 748,355 748,310 $ 1,277 189,263 1,932,970 (21,930) (1,353,270) 45
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 119,658              
Currency translation adjustments $ 12,617              
Ending balance (in shares) at Jun. 30, 2023 127,986,101   127,986,101          
Ending balance at Jun. 30, 2023 $ 841,528 841,659 $ 1,280 198,106 2,010,212 (7,720) (1,360,219) (131)
Beginning balance (in shares) at Mar. 31, 2023     127,968,717          
Beginning balance at Mar. 31, 2023 788,008 788,129 $ 1,280 193,225 1,972,831 (19,034) (1,360,173) (121)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 58,665 58,597     58,597     68
Dividends declared (21,216) (21,216)     (21,216)      
Currency translation adjustments 10,923 10,923       10,923    
Derivative financial instruments (333) (333)       (333)    
Defined benefit obligations 677 677       677    
Available-for-sale investments 47 47       47    
Exercises of stock options (in shares)     4,417          
Exercises of stock options 105 105 $ 0 105        
Shares placed in treasury (46) (46)         (46)  
Stock-based compensation charges (in shares)     12,967          
Stock-based compensation charges 4,776 4,776   4,776        
Distributions to noncontrolling interests $ (78)             (78)
Ending balance (in shares) at Jun. 30, 2023 127,986,101   127,986,101          
Ending balance at Jun. 30, 2023 $ 841,528 $ 841,659 $ 1,280 $ 198,106 $ 2,010,212 $ (7,720) $ (1,360,219) $ (131)